VITIX & VITICOLOR

Vitix & Viticolor.

Vitix Gel is used to repigment patches of vitiligo. Viticolor on the other hand, is a skin dye that covers patches of vitligo.

Vitix Gel

VITIX® gel is an opaque, non-greasy gel, with a slightly granular appearance.

VITIX® gel has a totally innovative mode of action that re-establishes the physiological balance of free radicals in epidermal cells (melanocytes and keratinocytes).

Its patented active ingredient, (EXTRAMEL®), a product of plant origin, is rich in antioxidants and bound within microspheres.

Clinical sutdies show that repigmentation is increased by 50% when Vitix Gel is combined with phototherapy or sunlight exposure.

NAPPI Code: 717248001

Watch this video now

Viticolor

Viticolor is a skin camouflage gel that has been especially formulated with colouring and self tanning agents, to provide immediate as well as long lasting colour to depigmented areas of the skin.

Viticolor gel ‘s unique combination of pigments facilitates easy application and uniform spread of colour.

NAPPI Code: 717249001

Watch this video now

Clinical Studies with Vitix

Treatment of Vitiligo with Narrow-Band UVB and Topical Gel Containing Catalase and Superoxide Dismutase:

Acta Dermatovenerol Croat 2007;15(1):10-14

More than 50% repigmentation was noted in 57.9% of patients receiving Vitix Gel and narrow band UVB.

One responder pictured on the left (Figures 1 & 2)

Evaluation of the Efficacy and Tolerance of Vitix® in the Treatment of Vitiligo.

Azerbaijan Medical University, Department of dermatovenerology

13 of 27 patients showed greater than 50% repigmentation when Vitix was combined with sun exposure.

Vitix and Heliotherapy

Gauthier Y– CHU de Bordeaux (France) May-October 2003

In a left right comparative study of 20 patients, more than 50% of patients shown more repigmentation on the Vitix treated side.

Uso terapéutico del Extramel en vitiligo

Departamento de Dermatología, Hospital Militar “Dr. Carlos Arvelo”. Caracas, Venezuela

Of 45 patients treated with Vitix and sun exposure, 60% showed repigmentation (18% complete and 42% partial)

One responder pictured above (Figures 3 & 4)

Should you require copies of any of these clinical studies, please use the contact form to request them and PDFs of the studies will be emailed to you.